Cannabinoids and bipolar disorder

[1]  I. Melle,et al.  Indications of a dose–response relationship between cannabis use and age at onset in bipolar disorder , 2014, Psychiatry Research.

[2]  J. Rehm,et al.  Bipolar disorder and co-occurring cannabis use disorders: Characteristics, co-morbidities and clinical correlates , 2013, Psychiatry Research.

[3]  I. Melle,et al.  Additive effects of childhood abuse and cannabis abuse on clinical expressions of bipolar disorders , 2013, Psychological Medicine.

[4]  J. Rehm,et al.  Cannabis use and cannabis use disorders among individuals with mental illness. , 2013, Comprehensive psychiatry.

[5]  D. Miklowitz,et al.  Treatment of bipolar disorder , 2013, The Lancet.

[6]  A. Caspi,et al.  Reply to Rogeberg and Daly: No evidence that socioeconomic status or personality differences confound the association between cannabis use and IQ decline , 2013, Proceedings of the National Academy of Sciences.

[7]  M. Leboyer,et al.  Clinical features associated with trait-impulsiveness in euthymic bipolar disorder patients. , 2013, Journal of affective disorders.

[8]  K. Kendler,et al.  Expanding the domain of the understandable in psychiatric illness: an updating of the Jasperian framework of explanation and understanding , 2013, Psychological Medicine.

[9]  P. DeRosse,et al.  Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder , 2012, Psychiatry Research.

[10]  Richie Poulton,et al.  Persistent cannabis users show neuropsychological decline from childhood to midlife , 2012, Proceedings of the National Academy of Sciences.

[11]  P. Allebeck,et al.  Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts , 2012, BMC Psychiatry.

[12]  M. Dunn,et al.  Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis. , 2012, Experimental and clinical psychopharmacology.

[13]  M. Leboyer,et al.  Clinical expression of bipolar disorder type I as a function of age and polarity at onset: convergent findings in samples from France and the United States. , 2012, The Journal of clinical psychiatry.

[14]  E. Bora,et al.  The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. , 2012, Schizophrenia bulletin.

[15]  M. Nordentoft,et al.  Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances--systematic review and meta-analysis. , 2012, Addictive behaviors.

[16]  C. Adler,et al.  Diagnosing Alcohol and Cannabis Use Disorders in Adolescents With Bipolar Disorder: A Preliminary Investigation , 2012, Journal of dual diagnosis.

[17]  O. Ekinci,et al.  Relationship of trait impulsivity with clinical presentation in euthymic bipolar disorder patients , 2011, Psychiatry Research.

[18]  P. Baud,et al.  Impulsivity, aggression and suicidal behavior in unipolar and bipolar disorders. , 2011, Journal of affective disorders.

[19]  P. Moore,et al.  Endocannabinoid system dysfunction in mood and related disorders , 2011, Acta psychiatrica Scandinavica.

[20]  P. DeRosse,et al.  The MATRICS Consensus Cognitive Battery in Patients with Bipolar I Disorder , 2011, Neuropsychopharmacology.

[21]  Natania A. Crane,et al.  An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions , 2011, Journal of addiction medicine.

[22]  J. Peuskens,et al.  Effects of cannabis use on age at onset in schizophrenia and bipolar disorder , 2011, Schizophrenia Research.

[23]  J. Nurnberger,et al.  Cannabis involvement in individuals with bipolar disorder , 2011, Psychiatry Research.

[24]  I. Melle,et al.  Excessive cannabis use is associated with earlier age at onset in bipolar disorder , 2011, European Archives of Psychiatry and Clinical Neuroscience.

[25]  J. Miettunen,et al.  Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. , 2010, Schizophrenia bulletin.

[26]  W. Stiles,et al.  Systematic review of practice-based research on psychological therapies in routine clinic settings. , 2010, The British journal of clinical psychology.

[27]  P. DeRosse,et al.  Cannabis use disorders in schizophrenia: Effects on cognition and symptoms , 2010, Schizophrenia Research.

[28]  S. Dursun,et al.  Cannabidiol was ineffective for manic episode of bipolar affective disorder , 2010, Journal of psychopharmacology.

[29]  B. Gorzalka,et al.  The endocannabinoid system and the treatment of mood and anxiety disorders. , 2009, CNS & neurological disorders drug targets.

[30]  I. Melle,et al.  Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia , 2009, Psychological Medicine.

[31]  Raphael T. Gerraty,et al.  A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state. , 2009, Neuropsychology.

[32]  G. Kirov,et al.  Age-at-onset in bipolar-I disorder: mixture analysis of 1369 cases identifies three distinct clinical sub-groups. , 2009, Journal of affective disorders.

[33]  F. Moeller,et al.  Increased trait-like impulsivity and course of illness in bipolar disorder. , 2009, Bipolar disorders.

[34]  Ellen Leibenluft,et al.  Schedule for affective disorders and schizophrenia for school-age children (K-SADS-PL) for the assessment of preschool children--a preliminary psychometric study. , 2009, Journal of psychiatric research.

[35]  R. Murray,et al.  The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning , 2009, Psychological Medicine.

[36]  J. Goldberg,et al.  Age at onset of bipolar disorder and risk for comorbid borderline personality disorder. , 2009, Bipolar disorders.

[37]  E. Bora,et al.  Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. , 2009, Journal of affective disorders.

[38]  J. Calabrese,et al.  A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. , 2009, The Journal of clinical psychiatry.

[39]  J. van os,et al.  Does Cannabis Use Affect Treatment Outcome in Bipolar Disorder?: A Longitudinal Analysis , 2009, The Journal of nervous and mental disease.

[40]  P. Munk-Jørgensen,et al.  Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence. , 2007, The American journal on addictions.

[41]  J. Os,et al.  Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives , 2007, Psychological Medicine.

[42]  I. Torres,et al.  Neuropsychological functioning in euthymic bipolar disorder: a meta‐analysis , 2007, Acta psychiatrica Scandinavica. Supplementum.

[43]  Stephen M Strakowski,et al.  The prevalence and significance of substance use disorders in bipolar type I and II disorder , 2007, Substance abuse treatment, prevention, and policy.

[44]  Karen I Bolla,et al.  The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task. , 2007, Drug and alcohol dependence.

[45]  R. Gonzalez.  Acute and Non-acute Effects of Cannabis on Brain Functioning and Neuropsychological Performance , 2007, Neuropsychology Review.

[46]  R. Mechoulam,et al.  Cannabidiol – Recent Advances , 2007, Chemistry & biodiversity.

[47]  R. de Graaf,et al.  Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population? , 2007, Addiction.

[48]  Peter B. Jones,et al.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review , 2007, The Lancet.

[49]  R. Kessler,et al.  Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. , 2007, Archives of general psychiatry.

[50]  R. de Graaf,et al.  Cannabis use and expression of mania in the general population. , 2006, Journal of affective disorders.

[51]  B. Grant,et al.  Cannabis use disorders in the USA: prevalence, correlates and co-morbidity , 2006, Psychological Medicine.

[52]  Michael F. Green,et al.  Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. , 2006, The Journal of clinical psychiatry.

[53]  Peter Gallagher,et al.  A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. , 2006, Journal of affective disorders.

[54]  B. Gorzalka,et al.  Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test , 2005, European Neuropsychopharmacology.

[55]  B. Grant,et al.  Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. , 2005, The Journal of clinical psychiatry.

[56]  M. Tohen,et al.  Substance abuse in first-episode bipolar I disorder: indications for early intervention. , 2005, The American journal of psychiatry.

[57]  A. Young,et al.  Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential , 2005, Journal of psychopharmacology.

[58]  Ralitza Gueorguieva,et al.  The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis , 2004, Neuropsychopharmacology.

[59]  M. Tohen,et al.  The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. , 2003, The American journal of psychiatry.

[60]  I. Grant,et al.  Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study , 2003, Journal of the International Neuropsychological Society.

[61]  M. Rietschel,et al.  Age at onset in bipolar I affective disorder: further evidence for three subgroups. , 2003, The American journal of psychiatry.

[62]  G. Sachs,et al.  Age onset of psychotic versus non-psychotic bipolar illness in men and in women. , 2003, Journal of affective disorders.

[63]  S. Cichon,et al.  Further evidence for age of onset being an indicator for severity in bipolar disorder. , 2002, Journal of affective disorders.

[64]  B. Carroll,et al.  Substance abuse in bipolar disorder. , 2001, Bipolar disorders.

[65]  M. Albanese,et al.  Divalproex sodium in substance abusers with mood disorder. , 2000, The Journal of clinical psychiatry.

[66]  D. Kupfer,et al.  Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry. , 2000, Bipolar disorders.

[67]  M. Hertzman,et al.  Divalproex sodium to treat concomitant substance abuse and mood disorders. , 2000, Journal of substance abuse treatment.

[68]  M. Leboyer,et al.  Early and late onset bipolar disorders: two different forms of manic-depressive illness? , 2000, Journal of affective disorders.

[69]  H. Akiskal,et al.  Alcoholism and drug abuse in three groups--bipolar I, unipolars and their acquaintances. , 1998, Journal of Affective Disorders.

[70]  J. Bakalar,et al.  The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research. , 1998, Journal of psychoactive drugs.

[71]  T. Cooper,et al.  Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

[72]  Robert M. Post,et al.  Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP , 1997, Psychiatry Research.

[73]  K. Brady,et al.  Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. , 1995, The Journal of clinical psychiatry.

[74]  S. Dilsaver,et al.  Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey. , 1995, The American journal of psychiatry.

[75]  A. Damasio,et al.  Insensitivity to future consequences following damage to human prefrontal cortex , 1994, Cognition.

[76]  D S Rae,et al.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. , 1990, JAMA.

[77]  T. McGlashan.  Adolescent versus adult onset of mania. , 1988, The American journal of psychiatry.

[78]  J. Russell,et al.  Bipolar Affective Disorder in Adolescence: A 10-Year Study , 1987, The Australian and New Zealand journal of psychiatry.

[79]  G. Klerman,et al.  Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. , 1986, JAMA.

[80]  R. C. Young,et al.  A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.

[81]  J. Angst,et al.  The course of affective disorders , 1978, Archiv für Psychiatrie und Nervenkrankheiten.

[82]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[83]  B. Cohen,et al.  Clinical characteristics influencing age at onset in psychotic disorders. , 2009, Comprehensive psychiatry.

[84]  S. Strakowski,et al.  Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania. , 2007, Archives of general psychiatry.

[85]  A. Malhotra,et al.  Cognitive Dysfunction in Bipolar Disorder , 2007, CNS drugs.

[86]  S. Strakowski,et al.  Twelve-month outcome after a first hospitalization for affective psychosis. , 1998, Archives of general psychiatry.

[87]  H. Pope,et al.  Do patients use marijuana as an antidepressant? , 1996, Depression.